These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32473178)

  • 61. Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer.
    Sugie T; Sato E; Miyashita M; Yamaguchi R; Sakatani T; Kozuka Y; Moritani S; Suzuki E; Kakimi K; Mikami Y; Moriya T
    Breast Cancer; 2020 Jul; 27(4):519-526. PubMed ID: 32447649
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules.
    D'Arrigo P; Tufano M; Rea A; Vigorito V; Novizio N; Russo S; Romano MF; Romano S
    Curr Med Chem; 2020; 27(15):2402-2448. PubMed ID: 30398102
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Designer Scaffold with Immune Nanoconverters for Reverting Immunosuppression and Enhancing Immune Checkpoint Blockade Therapy.
    Phuengkham H; Song C; Lim YT
    Adv Mater; 2019 Oct; 31(42):e1903242. PubMed ID: 31490604
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The predictive and prognostic value of Foxp3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer.
    Zhang L; Wang XI; Ding J; Sun Q; Zhang S
    Ann Diagn Pathol; 2019 Jun; 40():143-151. PubMed ID: 31096176
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy.
    Liu J; Liu Q; Zhang X; Cui M; Li T; Zhang Y; Liao Q
    Cancer Cell Int; 2021 Feb; 21(1):137. PubMed ID: 33637086
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9
    Chen H; Cong X; Wu C; Wu X; Wang J; Mao K; Li J; Zhu G; Liu F; Meng X; Song J; Sun X; Wang X; Liu S; Zhang S; Yang X; Song Y; Yang YG; Sun T
    Sci Adv; 2020 Jan; 6(5):eaax4690. PubMed ID: 32064335
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer.
    Naik A; Monjazeb AM; Decock J
    Front Immunol; 2019; 10():1940. PubMed ID: 31475003
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
    McArthur HL; Page DB
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immuno-reactive cancer organoid model to assess effects of the microbiome on cancer immunotherapy.
    Shelkey E; Oommen D; Stirling ER; Soto-Pantoja DR; Cook KL; Lu Y; Votanopoulos KI; Soker S
    Sci Rep; 2022 Jun; 12(1):9983. PubMed ID: 35705580
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano-immunotherapy in Breast Cancer Lung Metastasis.
    Mpekris F; Panagi M; Voutouri C; Martin JD; Samuel R; Takahashi S; Gotohda N; Suzuki T; Papageorgis P; Demetriou P; Pierides C; Koumas L; Costeas P; Kojima M; Ishii G; Constantinidou A; Kataoka K; Cabral H; Stylianopoulos T
    Adv Sci (Weinh); 2021 Feb; 8(3):2001917. PubMed ID: 33552852
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Co-delivery of gemcitabine and paclitaxel plus NanoCpG empowers chemoimmunotherapy of postoperative "cold" triple-negative breast cancer.
    Guo B; Qu Y; Sun Y; Zhao S; Yuan J; Zhang P; Zhong Z; Meng F
    Bioact Mater; 2023 Jul; 25():61-72. PubMed ID: 36733927
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of tumor gene mutations in treatment response to immune checkpoint blockades.
    Wang M; Yu L; Wei X; Wei Y
    Precis Clin Med; 2019 Jun; 2(2):100-109. PubMed ID: 35692451
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Peptide nano 'bead-grafting' for SDT-facilitated immune checkpoints blocking.
    Zhang L; Tian Y; Li M; Wang M; Wu S; Jiang Z; Wang Q; Wang W
    Chem Sci; 2022 Dec; 13(47):14052-14062. PubMed ID: 36540822
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New Single-Cell Screening Method Finds Immunotherapy Response Modulator.
    Cancer Discov; 2021 May; 11(5):1005. PubMed ID: 33712488
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Editorial: Immunological Effects of Nano-Imaging Materials.
    Li Y; Zhang P; Tang BZ; Boraschi D
    Front Immunol; 2022; 13():886415. PubMed ID: 35401571
    [No Abstract]   [Full Text] [Related]  

  • 76. THE HIGHLY STRUNG NERVOUS SYSTEM.
    Rankin G
    Br Med J; 1916 Oct; 2(2912):545-8. PubMed ID: 20768336
    [No Abstract]   [Full Text] [Related]  

  • 77. Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis.
    Rao L; Wu L; Liu Z; Tian R; Yu G; Zhou Z; Yang K; Xiong HG; Zhang A; Yu GT; Sun W; Xu H; Guo J; Li A; Chen H; Sun ZJ; Fu YX; Chen X
    Nat Commun; 2020 Sep; 11(1):4909. PubMed ID: 32999291
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    Chen C; Zhang S; Zhang R; Sun P; Shi C; Abdalla M; Li A; Xu J; Du W; Zhang J; Liu Y; Tang C; Yang Z; Jiang X
    Theranostics; 2020; 10(26):11998-12010. PubMed ID: 33204325
    [No Abstract]   [Full Text] [Related]  

  • 79. Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection.
    Zhang J; Chen C; Li A; Jing W; Sun P; Huang X; Liu Y; Zhang S; Du W; Zhang R; Liu Y; Gong A; Wu J; Jiang X
    Nat Nanotechnol; 2021 May; 16(5):538-548. PubMed ID: 33526838
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells.
    Candas-Green D; Xie B; Huang J; Fan M; Wang A; Menaa C; Zhang Y; Zhang L; Jing D; Azghadi S; Zhou W; Liu L; Jiang N; Li T; Gao T; Sweeney C; Shen R; Lin TY; Pan CX; Ozpiskin OM; Woloschak G; Grdina DJ; Vaughan AT; Wang JM; Xia S; Monjazeb AM; Murphy WJ; Sun LQ; Chen HW; Lam KS; Weichselbaum RR; Li JJ
    Nat Commun; 2020 Sep; 11(1):4591. PubMed ID: 32929084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.